Williams secures $5.3 billion investment from Blackstone-led group-August 2024-www.financetom.com

Williams secures $5.3 billion investment from Blackstone-led group

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Williams secures $5.3 billion investment from Blackstone-led group

Jul 13, 2026 6:55 AM

July 13 (Reuters) - Williams said on Monday a

consortium led by Blackstone will invest $5.34 billion

for a 49% noncontrolling stake in five of its behind-the-meter

power generation projects.

Previous page： Cardiac muscle therapeutics firm Cytokinetics Q3 net loss widens Next page： World Kinect Corporation Completes Acquisition of Universal Weather and Aviation's Trip Support Services Business

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Cardiac muscle therapeutics firm Cytokinetics Q3 net loss widens

Nov 5, 2025

Overview * Cytokinetics ( CYTK ) Q3 net loss widens to $306.2 mln, driven by debt conversion expense * Company reports Q3 revenue of $1.9 mln, up from $0.5 mln last year * Cytokinetics ( CYTK ) prepares for potential U.S. launch of aficamten pending FDA approval Outlook * Company expects EMA decision on aficamten MAA in 1H 2026 *...

World Kinect Corporation Completes Acquisition of Universal Weather and Aviation's Trip Support Services Business

Nov 5, 2025

MIAMI--(BUSINESS WIRE)-- World Kinect Corporation ( WKC ) today announced that it has completed its previously announced acquisition of the Trip Support Services (TSS) division of Universal Weather and Aviation. Universal Weather, headquartered in Houston, Texas, has been a pioneer in trip support services with deep expertise in international travel regulations, logistics, and supply chain management. Its trip support business...

Jazz Pharmaceuticals Q3 revenue beats estimates

Nov 5, 2025

Overview * Jazz Pharmaceuticals ( JAZZ ) Q3 revenue grows 7% yr/yr, beating analyst expectations * Adjusted EPS for Q3 beats consensus, reflecting robust operational performance * Company narrows 2025 revenue guidance to $4.175 - $4.275 bln Outlook * Company narrows 2025 revenue guidance to $4.175 - $4.275 bln * Jazz Pharmaceuticals ( JAZZ ) expects top-line data from zanidatamab...

Delaware judge says she will not block Metsera from ending Pfizer deal

Nov 5, 2025

WILMINGTON, Delaware, Nov 5 (Reuters) - A Delaware judge said on Wednesday she would reject a request by Pfizer ( PFE ) to temporarily block Metsera ( MTSR ) from terminating its takeover deal with Pfizer ( PFE ), allowing Metsera ( MTSR ) to proceed instead with a higher $10 billion deal from Novo Nordisk. ...